SHL Telemedicine closes first of two capital increases

Press release

SHL Telemedicine closes first of two capital increases

Tel Aviv / Zurich, January 21, 2021- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced that it has issued 1,300,000 new ordinary shares from authorized capital today (the "New Shares"). The New Shares will be listed on SIX Swiss Exchange on January 22, 2021.

Following this issuance, the number of SHL shares issued increases by 11.95% from 10,878,491 to 12,178,491. In addition, 800,000 options to purchase ordinary shares of the Company, have been granted on January 21, 2021, to be newly issued from the authorized capital upon exercise ("Share Options", ratio 1:1, exercise price CHF 11.00, exercise period 24 months). The New Shares, along with 300,000 treasury shares and the 800,000 Share Options, will be placed by way of a private placement. The issue price for the New Shares is CHF 9.00. No subscription rights of the existing shareholders apply.

Today's share issuance is the first of two capital increases as announced on December 17, 2020. The second capital increase comprising the issuance and placement of further 2,288,889 new ordinary shares and 1,144,444 options is expected to be performed later in February.

SHL's share capital before and after the capital increases and placements

Authorized capital - number of ordinary shares at par value of NIS 0.01 each		25,000,000
	Issued	10,878,491
Ordinary shares of NIS 0.01 par value each on January 20, 2021	Of which treasury shares	364,037
Ordinary shares of NIS 0.01 par value each on January 21, 2021, following thefirst capital increase and placement	Issued	12,178,491
	Of which treasury shares	64,037
Ordinary shares of NIS 0.01 par value each following thesecond capital increase and placement	Issued (assuming no Share Options being exercised)	14,467,380
	Of which treasury shares (assuming no options from employee share option plan being exercised)	64,037

Further information

Martin Meier-Pfister, IRF, Phone: [phone], [e-mail]

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit our web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.

Press release (PDF)

Provider		Channel		Contact
EQS Group Ltd., Switzerland switzerland.eqs.com		newsbox.ch www.newsbox.ch		Provider/Channel related enquiries [e-mail] [phone]